The COVID Advisor

A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. New Study Defines Mechanisms of Post-mRNA Vaccine “Turbo Cancer” Peer-reviewed research from Drs. Paul Marik and Justus Hope links COVID-19 mRNA vaccines to “turbo cancer,” detailing five biological pathways that may drive aggressive, fast-growing cancers. Dr. Paul Marik, chief scientific officer and co-founder of the Independent Medical Alliance, isn’t one to shy away from hard truths. In his video statement below, accompanying the release of a new peer-reviewed paper , he described what doctors and nurses around the world have been seeing since 2021: more aggressive cancers, affecting younger patients, and returning with a vengeance in people once in remission — often within weeks of a COVID-19 booster shot. The paper, co-authored ...

If you've had COVID-19 or know someone who has, you've likely seen how the illness lingers. Unresolved fatigue, reduced physical capacity, and cognitive fog are common weeks or even months after the infection clears. In more severe cases, the virus left behind lasting damage to the kidneys, lungs, or vascular system. These outcomes are now recognized as long COVID. As attention shifts from short-term containment to long-term recovery, more researchers are focusing on the cellular pathways that support resilience after viral illness. One area drawing renewed attention is the use of nicotinamide adenine dinucleotide (NAD⁺), a molecule your cells use to produce energy, repair DNA, regulate inflammation, and maintain mitochondrial function. One of the most straightforward ways to raise NAD⁺ safely and effectively is through niacinamide, a common and inexpensive form of vitamin B3. Case in point, a new placebo-controlled trial published in Nature Metabolism has highlighted niacinami...